EMA revises Process Validation Guideline
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The News "Detailed analysis of EMA's new Guideline on Process Validation" from March 2014 reported about EMA's revised process validation guideline entitled "Guideline on process validation for finished products - information and data to be provided in regulatory submissions". Now, the European Medicines Agency has surprinsingly published a new revision.
Why this revision? What has changed?
Beforehand, please note that the changes are marginal and characterised as "minor update" by the EMA. Solely the definition for "on-line measurement" has been incorporated into the glossary. For the EMA, this is not a complete revision and thus there will be no consultation phase.
For further details please refer to the "Guideline on process validation for finished products - information and data to be provided in regulatory submissions" issued on 21 November.
Related GMP News
02.09.2026Cloud Computing: Authorities' Expectations od Cloud Service Providers?
26.08.2026Cloud Computing: IT Infrastructure Qualification by a SAAS Provider
26.08.2026Detailed Analysis of the PIC/S Document 'Recommendations on Qualification and Validation' - Part II
19.08.2026Cloud Computing: How can CSPs Achieve the Annex 11 Requirement of Qualified Infrastructure?
19.08.2026Detailed Analysis of the PIC/S Document 'Recommendations on Qualification and Validation' - Part I
12.08.2026Media Fill - What are the FDA's Issues?